期刊文献+

CD4^+CD25^+调节性T细胞对乳腺癌细胞上皮间质转化和ALDH1^+干样细胞的影响 被引量:5

CD4^+ CD25^+ regulatory T cells induce epithelial- mesenchymal transition and increase ALDH1^+ cancer stem cell-like cells in breast cancer
下载PDF
导出
摘要 目的:研究CD4^+CD25^+调节性T细胞(regulatory T cells,Tregs)对乳腺癌细胞上皮间质转化(epithelial-mesenchymal transition,EMT)、细胞迁移侵袭能力,及ALDH1^+干样细胞比例的影响。方法:采用免疫磁珠法分离乳腺癌患者外周血中CD4^+CD25^+Tregs,CD4^+CD25^+Tregs与乳腺癌BT474、MCF-7细胞系共培养(共培养组),BT474、MCF-7单独培养(对照组)。检测共培养组和对照组乳腺癌细胞EMT相关标志物表达的变化,及细胞迁移和侵袭能力的变化。此外,检测BT474细胞中ALDH1^+干样细胞、微球形成能力和自我更新能力的变化。结果:CD4^+CD25^+Tregs诱导BT474和MCF-7细胞间质性标志物表达增高,诱导MCF-7细胞上皮性标志物E-cadherin表达降低。CD4^+CD25^+Tregs诱导BT474和MCF-7细胞迁移和侵袭能力上调。共培养组BT474细胞中ALDH1^+干样细胞比例、微球体形成能力、自我更新能力较对照组增强。结论:CD4^+CD25^+Tregs可诱导乳腺癌细胞发生EMT,增强细胞体外迁移和侵袭能力,同时促进ALDH1^+干样细胞增加。 Objective: To investigate the effects of CD4+CD25+ regulatory T cells (Tregs) on the epithelial-mesenchymal transition (EMT), migratory and invasive capacities, and proportion of ALDH1+ cancer stern cell (CSC)-Iike cells in breast cancer cells. Methods: CD4+CD25+ Tregs were isolated from the peripheral blood of breast cancer patients through immunomagnetic sand method. In the co-culture groups, breast cancer cell lines BT474 and MCF-7 were co-cultured with CD4+CD25+Tregs. In the control groups, BT474 and MCF-7 cells were cultured alone. EMT-related markers of breast cancer cells were then assayed in the control and co-culture groups. The migrato- ry and invasive capacities of breast cancer cells were also detected in both groups. Furthermore, the changes in ALDHI+CSC-like cells, mammosphere-forming ability, and se+f-renewal capacity of BT474 cells were assayed. Results: After co-culture with CD4+CD2S+Tregs, the expression of mesenchymal biomarkers increased in BT474 and MCF-7 cells, whereas the expression of the epithelial biomarker E- cadherin decreased in MCF-7 cells. Additionally, the migratory and invasive capacities of BT474 and MCF-7 cells increased after co-cul- ture. Overall, the subpopulation of ALDH1+CSC-iike cells, the mammosphere-forming ability, and the self-renewal capacity of BT474 cells improved in the co-culture group compared with the control group. Conclusion: The EMT process, migratory and invasive capaci- ties, and CSC-like properties of breast cancer cells can be enhanced by CD4+CD25+regs.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2016年第5期177-182,共6页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金项目(编号:81171983)资助~~
关键词 调节性T细胞乳腺癌上皮间质转化ALDH1+干样细胞 regulatory T cells, breast cancer, epithelial-mesenchymal transition, ALDH1+cancer stem cell-like cells
  • 相关文献

参考文献15

  • 1Redig A J, McAllister SS. Breast cancer as a systemic disease: a view of metastasis[J]. J Intern Med, 2013, 274(2):113-126.
  • 2Gomes LR, Terra LF, Sogayar MC, et al. Epithelial-mesenchymal transition: implications in cancer progression and metastasis[J]. Curr Pharm Biotechnol, 2011, 12(11):1881-1890.
  • 3Li S, Li Q. Cancer stem cells and tumor metastasis (Review) [J]. Int J Oncol, 2014, 44(6):2806-1822.
  • 4Iqbal J, Chong PY, Tan PH. Breast cancer stem cells: an update[J]. J Clin Pathol, 2013, 66(6):485-490.
  • 5Fuxe J, Karlsson MC. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation[J]. Semin Cancer Biol, 2012, 22(5-6):455-461.
  • 6Chang we, Li CH, Huang SC, et al. Clinical significance of regulatory T cells and CD8^+ effector populations in patients with human endometrial carcinoma[J]. Cancer, 2010, 116(24):5777-5788.
  • 7Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma[J]. J Immunol, 2002, 169(5):2756-2761.
  • 8Acloque H, Adams MS, Fishwick K, et al. Epithelial-mesenchymal transitions: the importance of changing ceil state in development and disease[J]. J Clin Invest, 2009, 119(6):2438-1449.
  • 9De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression[J]. Nat Rev Cancer, 2023, 23(2):97- 120.
  • 10Foroni C, Broggini M, Generali D, et al. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact[J]. Cancer Treat Rev, 2012, 38(6):689-697.

同被引文献109

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部